Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan.

Authors
  • Kurita, Tomoko1
  • Kitaichi, Tomomi
  • Nagao, Takako
  • Miura, Toshiyuki
  • Kitazono, Yoshifumi
  • 1 ViiV Healthcare K.K., Tokyo, 151-8566, Japan. , (Japan)
Type
Published Article
Journal
Pharmacoepidemiology and drug safety
Publication Date
Apr 01, 2014
Volume
23
Issue
4
Pages
372–381
Identifiers
DOI: 10.1002/pds.3588
PMID: 24590575
Source
Medline
Keywords
License
Unknown

Abstract

The post-marketing surveillance indicated that the incidence of both ischaemic heart disease and hypersensitivity associated with Epzicom was considerably low, suggesting that this drug can be safely used in the Japanese population.

Report this publication

Statistics

Seen <100 times